The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 81.00
Bid: 77.20
Ask: 80.80
Change: 0.00 (0.00%)
Spread: 3.60 (4.663%)
Open: 81.00
High: 0.00
Low: 0.00
Prev. Close: 81.00
TRI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ANNUAL GENERAL MEETING - STATEMENT TO SHAREHOLDERS

22 Sep 2020 07:00

RNS Number : 6482Z
Trifast PLC
22 September 2020
 

 

 

Tuesday, 22 September 2020

 

Trifast plc

(Trifast, Group or Company)

 

Leading international specialists in the design, engineering, manufacture and distribution

of high quality industrial and Category 'C' components principally to major global assembly industries

 

"Our fastenings enable innovation today to build a better tomorrow"

 

 

ANNUAL GENERAL MEETING - STATEMENT TO SHAREHOLDERS

 

 

 

ANNUAL GENERAL MEETING (Meeting)

At today's Meeting (12 noon), Non-Executive Chair, Jonathan Shearman will make the following statement on behalf of the Board:

 

"In the year to 31 March 2020 (FY2020), we experienced challenging market conditions, more latterly compounded by the outbreak of a global pandemic. Given this, we were pleased to maintain revenues above £200m, with an operating profit margin of 9%.

We have consistently paid testament to our people, and it is worth doing so again. I remain delighted to witness how, during the past months, our teams have pulled together and supported each other in a truly Group fashion. We continue to prioritise the welfare of our staff and operational working practices have been adjusted, across all our locations, to ensure a safe working environment.

Elsewhere, swift and effective action ensured the impact of COVID-19 has been limited and we are also proud to have supported our customers through such a difficult time. A further part of this action was the equity raise undertaken in June. We thank shareholders for their continued support which gives the Board the capability to accelerate the Group's performance as its markets recover, as well as confidence to continue with our strategic plans.

The effects of the global pandemic unsurprisingly, dominated the early months of FY2021. In trading terms, during Q1, this led to a general reduction in industrial volumes and a meaningful reduction in year-on-year revenue. As we approach the end of Q2, we are pleased to report that each of the months from April to July saw a sequential increase in revenue before a seasonally quieter August. Furthermore, the Board is encouraged that as a result, H1 revenue has been slightly ahead of our FY2021 base case assumptions (previously reported as FY2021 revenue c.16% below prior year).

There can be no doubt that the macroeconomic environment remains unpredictable. However, we are pleased to report that our pipeline and activity levels around the Group remain encouraging. Additional prospects for growth are being actively targeted with a number already secured, and further business development activity underway across several sectors including electric vehicle, 5G and medical.

As we said in the Annual Report, we continue to plan for the future so as to ensure TR is in the best possible position to make the most of the current uncertain times but more importantly to move rapidly forward when more stability returns to the global environment."

 

NOTICE OF HALF-YEAR RESULTS

The Company looks forward to updating shareholders further on progress at our next trading update to be released in October, ahead of half-yearly results which are currently scheduled for Tuesday, 24 November 2020. Further information on this event will be added to the website in due course.

 

 

 

 

Further enquiries please contact:

 

Trifast plc

Jonathan Shearman, Non-Executive Chair

Mark Belton, Chief Executive Officer

Clare Foster, Chief Financial Officer

Tel: +44 (0) 1825 747630

Email: corporate.enquiries@trifast.com

 

Peel Hunt LLP 

Stockbroker & financial adviser

Mike Bell

Tel: +44 (0)20 7418 8900

TooleyStreet Communications

IR & media relations

Fiona Tooley

Tel: +44 (0)7785 703523

Email:fiona@tooleystreet.com

 

 

Editors' note:

 

LSE Premium Listing: Ticker: TRI

 

LEI number: 213800WFIVE6RUK3CR22

 

Trifast plc (TR) is an international specialist in the design, engineering, manufacture and distribution of high quality industrial and Category 'C' components principally to major global assembly industries.

 

TR employs c.1,300 people across 33 business locations within the UK, Asia, Europe, and the USA including eight high-volume, high-quality, and cost-effective manufacturing sites across the world. TR supplies to over 5,000 customers in >75 countries worldwide, with no one customer representing greater than 7% of revenue. As a full-service provider to multinational OEMs and Tier 1 companies spanning several sectors, TR delivers comprehensive support to its customers across every requirement, from concept design through to technical engineering consultancy, manufacturing, supply management and global logistics.

 

For more information, visit

Investor website: www.trifast.com

Commercial website: www.trfastenings.com

LinkedIn: www.linkedin.com/company/tr-fastenings

Twitter: www.twitter.com/trfastenings

Facebook:www.facebook.com/trfastenings

https://www.londonstockexchange.com/stock/TRI/trifast-plc/our-story

 

The 2020 Annual Report can be viewed and downloaded on the Company's website at http://www.trifast.com/investors/our-reports/.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUAAKRRUUKUAR
Date   Source Headline
25th Apr 20247:00 amRNSTrading update & Notice of Annual results
15th Apr 20242:11 pmRNSDirector/PDMR Shareholding
15th Apr 20241:07 pmRNSDirector/PDMR Shareholding
4th Apr 202410:40 amRNSBlock listing Interim Review
21st Mar 20247:00 amRNSDirector/PDMR Shareholding - Purchase of shares
13th Mar 20242:30 pmRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSAppointment & retirement of non-executive director
22nd Feb 20247:00 amRNSDirectorate Change
9th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 202410:09 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 20249:33 amRNSHolding(s) in Company
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 202411:23 amRNSDirector/PDMR Shareholding
22nd Jan 20243:20 pmRNSDirector/PDMR Shareholding
22nd Jan 20247:00 amRNSTrading Update
3rd Jan 20245:50 pmRNSTotal Voting Rights
21st Dec 20234:24 pmRNSHolding(s) in Company
21st Dec 20234:18 pmRNSHolding(s) in Company
15th Dec 20237:00 amRNSNon executive director retirement update
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSPDMR - Performance conditions for LTIP award
24th Nov 20232:34 pmRNSDirector/PDMR shareholding - Purchase of shares
21st Nov 20237:00 amRNSHalf-year Report - six months to 30 September 2023
24th Oct 20237:00 amRNSHalf year trading update and notice of results
19th Oct 20237:00 amRNSNon-executive Director appointment
12th Oct 20237:00 amRNSDirectorate retirement
3rd Oct 20234:16 pmRNSBlock listing Interim Review
25th Sep 20233:49 pmRNSHolding(s) in Company
19th Sep 20234:45 pmRNSPDMR Save As You Earn Plan grant of Option
15th Sep 20233:05 pmRNSResult of AGM
15th Sep 20239:15 amRNSCEO appointment
14th Sep 20234:48 pmRNSDirectorate Change
29th Aug 20237:00 amRNSHolding(s) in Company
10th Aug 20237:00 amRNSBoard Appointment
3rd Aug 202311:36 amRNSDirector/PDMR Shareholding
19th Jul 20232:31 pmRNSHolding(s) in Company
19th Jul 20237:00 amRNSAR posting - AGM - Sustainability report & TVR
17th Jul 20231:25 pmRNSHolding(s) in Company
11th Jul 20237:00 amRNSAnnual results - 31 March 2023 - Annual Report
9th Jun 20237:00 amRNSNotice of Annual Results
10th May 202311:38 amRNSHolding(s) in Company
4th May 20233:50 pmRNSDirector Declaration
26th Apr 20237:00 amRNSTrading update
4th Apr 20234:45 pmRNSTotal Voting Rights
4th Apr 20234:43 pmRNSBlock listing Interim Review
29th Mar 20234:47 pmRNSHolding(s) in Company
28th Feb 20236:16 pmRNSPDMR Shareholding
28th Feb 20231:38 pmRNSDirector/PDMR Shareholdings
27th Feb 20233:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.